Vise Technologies Inc. Makes New $329,000 Investment in Kenvue Inc. $KVUE

Vise Technologies Inc. acquired a new stake in Kenvue Inc. (NYSE:KVUE) in the second quarter, Holdings Channel.com reports. The firm acquired 15,712 shares of the company’s stock, valued at approximately $329,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Trust Co. of Vermont lifted its holdings in Kenvue by 266.8% during the second quarter. Trust Co. of Vermont now owns 1,581 shares of the company’s stock valued at $33,000 after purchasing an additional 1,150 shares in the last quarter. Truvestments Capital LLC acquired a new position in shares of Kenvue during the 1st quarter worth about $37,000. Clal Insurance Enterprises Holdings Ltd boosted its holdings in Kenvue by 378.5% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 1,627 shares of the company’s stock worth $39,000 after buying an additional 1,287 shares during the last quarter. Bank Julius Baer & Co. Ltd Zurich boosted its stake in shares of Kenvue by 120.6% in the first quarter. Bank Julius Baer & Co. Ltd Zurich now owns 1,699 shares of the company’s stock worth $41,000 after acquiring an additional 929 shares during the last quarter. Finally, First Pacific Financial purchased a new stake in shares of Kenvue during the second quarter worth approximately $54,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the stock. JPMorgan Chase & Co. lowered their target price on shares of Kenvue from $24.00 to $21.00 and set an “overweight” rating on the stock in a research note on Friday, October 10th. Edward Jones downgraded shares of Kenvue from a “strong-buy” rating to a “hold” rating in a research note on Monday, November 3rd. Barclays upped their price objective on shares of Kenvue from $17.00 to $18.00 and gave the company an “equal weight” rating in a research note on Monday, November 10th. Canaccord Genuity Group reaffirmed a “hold” rating and set a $15.00 target price (down from $26.00) on shares of Kenvue in a research note on Wednesday, October 29th. Finally, Rothschild Redb upgraded shares of Kenvue from a “hold” rating to a “strong-buy” rating in a report on Friday, September 26th. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, twelve have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $20.23.

Kenvue Stock Down 0.6%

Shares of Kenvue stock opened at $16.68 on Monday. The company has a quick ratio of 0.69, a current ratio of 0.98 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 52-week low of $14.02 and a 52-week high of $25.17. The company has a market capitalization of $31.95 billion, a P/E ratio of 22.23, a P/E/G ratio of 2.43 and a beta of 0.71. The company has a 50 day moving average of $16.42 and a 200 day moving average of $20.03.

Kenvue (NYSE:KVUE) last announced its quarterly earnings data on Monday, November 3rd. The company reported $0.28 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.01. Kenvue had a net margin of 9.55% and a return on equity of 20.02%. The business had revenue of $3.76 billion for the quarter, compared to analyst estimates of $3.83 billion. During the same period last year, the business earned $0.28 EPS. The company’s revenue was down 3.5% on a year-over-year basis. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, research analysts forecast that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, November 26th. Stockholders of record on Wednesday, November 12th will be given a dividend of $0.2075 per share. The ex-dividend date is Wednesday, November 12th. This represents a $0.83 dividend on an annualized basis and a dividend yield of 5.0%. Kenvue’s dividend payout ratio (DPR) is 110.67%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.